Citation: Bc. Mcclaine et al., X-ray and IR spectroscopy of barium-promoted, zeolite-supported ruthenium catalysts for ammonia synthesis, J PHYS CH B, 105(31), 2001, pp. 7525-7532
Authors:
Lu, BF
Yu, H
Chow, CW
Li, BY
Zheng, WP
Davis, RJ
Flavell, RA
Citation: Bf. Lu et al., GADD45 gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector T(H)1 cells, IMMUNITY, 14(5), 2001, pp. 583-590
Authors:
Tournier, C
Dong, C
Turner, TK
Jones, SN
Flavell, RA
Davis, RJ
Citation: C. Tournier et al., MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines, GENE DEV, 15(11), 2001, pp. 1419-1426
Authors:
Davis, RJ
Shen, WP
Sandler, YI
Amoui, M
Purcell, P
Maas, R
Ou, CN
Vogel, H
Beaudet, AL
Mardon, G
Citation: Rj. Davis et al., Dach1 mutant mice bear no gross abnormalities in eye, limb, and brain development and exhibit postnatal lethality, MOL CELL B, 21(5), 2001, pp. 1484-1490
Authors:
Morishima, Y
Gotoh, Y
Zieg, J
Barrett, T
Takano, H
Flavell, R
Davis, RJ
Shirasaki, Y
Greenberg, ME
Citation: Y. Morishima et al., beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand, J NEUROSC, 21(19), 2001, pp. 7551-7560
Authors:
van der Lely, AJ
Hutson, RK
Trainer, PJ
Besser, GM
Barkan, AL
Katznelson, L
Klibanski, A
Herman-Bonert, V
Melmed, S
Vance, ML
Freda, PU
Stewart, PM
Friend, KE
Clemmons, DR
Johannsson, G
Stavrou, S
Cook, DM
Phillips, LS
Strasburger, CJ
Hacker, S
Zib, KA
Davis, RJ
Scarlett, JA
Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759
Authors:
Swithers, SE
Melendez, RI
Watkins, BA
Davis, RJ
Citation: Se. Swithers et al., Metabolic and behavioral responses in pre-weanling rats following alteration of maternal diet, PHYSL BEHAV, 72(1-2), 2001, pp. 147-157
Citation: Gs. De Zutter et Rj. Davis, Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway, P NAS US, 98(11), 2001, pp. 6168-6173
Authors:
Wu, HJ
Venkataraman, C
Estus, S
Dong, C
Davis, RJ
Flavell, RA
Bondada, S
Citation: Hj. Wu et al., Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation, J IMMUNOL, 167(3), 2001, pp. 1263-1273
Authors:
van der Lely, AJ
Muller, AF
Janssen, JA
Davis, RJ
Zib, KA
Scarlett, JA
Lamberts, SW
Citation: Aj. Van Der Lely et al., Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient, J CLIN END, 86(2), 2001, pp. 478-481
Authors:
Chen, PL
Hutter, D
Yang, XL
Gorospe, M
Davis, RJ
Liu, YS
Citation: Pl. Chen et al., Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically, J BIOL CHEM, 276(31), 2001, pp. 29440-29449
Authors:
Miller, WE
McDonald, PH
Cai, SF
Field, ME
Davis, RJ
Lefkowitz, RJ
Citation: We. Miller et al., Identification of a motif in the carboxyl terminus of beta-arrestin2 responsible for activation of JNK3, J BIOL CHEM, 276(30), 2001, pp. 27770-27777